Study of three patients with monoclonal gammopathies and 'lupus-like' anticoagulants

British Journal of Haematology
V BellottiE Ascari

Abstract

In three patients with monoclonal gammopathies: a case of multiple myeloma, a case of monoclonal gammopathy of uncertain significance (MGUS) and a case of monoclonal gammopathy associated with lymphocytic lymphoma, we found the presence of a circulating lupus-like anticoagulant. Coagulative studies showed that the paraproteins: an IgG3k, an IgG1k and an IgMlambda, were responsible for the anticoagulant activity by interacting with the thromboplastin phospholipids. Using isoelectrofocusing we demonstrated that the three monoclonal immunoglobulins had a strong basic charge which may have contributed to determining their interaction with the acidic thromboplastin phospholipids. The binding of various phospholipids to the monoclonal proteins was assessed by the fluorescence quenching method which showed heterogeneous specificity. In order to establish whether the electrical charge is also relevant in cases with polyclonal lupus anticoagulant, the polyclonal immunoglobulins were fractionated according to their charge. The strongest inhibitor activity was found in the most basic immunoglobulins. Monoclonal lupus-like anticoagulants represent useful tools for investigating the heterogeneous world of polyclonal lupus-like anticoagulants.

References

Jan 1, 1978·Acta Medica Scandinavica·O Zettervall, I M Nilsson
Sep 1, 1978·British Journal of Haematology·T ExnerH Kronenberg
Jun 1, 1985·American Journal of Clinical Pathology·G S ChapmanD L Danley
Jan 1, 1974·Haemostasis·K Lechner
Nov 1, 1965·The Journal of Clinical Investigation·H I Glueck, R Hong
Mar 1, 1980·The Journal of Clinical Investigation·M S KhooryK G Mann
Apr 1, 1981·The Journal of Experimental Medicine·E M LaferB D Stollar

❮ Previous
Next ❯

Citations

May 1, 1994·Annals of Hematology·M SawamuraJ Tsuchiya
Aug 16, 2001·International Journal of Hematology·A ShinagawaT Nagasawa
Apr 7, 2005·Digestive Diseases and Sciences·Darren A KastinAlan L Buchman
Mar 6, 2003·Reviews in Clinical and Experimental Hematology·Robert A Kyle, S Vincent Rajkumar
Feb 8, 2002·Clinical Chemistry and Laboratory Medicine : CCLM·G MerliniR Moratti
Jul 20, 2011·Leukemia & Lymphoma·Klaus LechnerIngrid Pabinger
Dec 1, 1995·Baillière's Clinical Haematology·R A Kyle
Mar 1, 1994·Giornale italiano di cardiologia·G FinazziT Barbui
Apr 18, 2006·Seminars in Arthritis and Rheumatism·José A Gómez-PuertaJosep Font
Sep 2, 2000·Journal of Autoimmunity·R A Asherson
Feb 14, 1998·American Journal of Hematology·I S LossosY Matzner
Dec 26, 2003·American Journal of Hematology·Osamu TakamiyaKatuhiko Kubara
Jul 9, 2003·Immunological Reviews·Robert A Kyle, S Vincent Rajkumar
Aug 1, 1992·British Journal of Haematology·J ArvieuxM G Colomb
Jan 21, 2021·Thrombosis and Haemostasis·Andrew J DoyleBeverley J Hunt

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.